St. Jude Medical Announces Leading Sponsorship Of Landmark Clinical Trial To Study Atrial Fibrillation
Links shared publicly online about this topic.
- 1,968total visits
St. Jude Medical Announces Leading Sponsorship Of Landmark Clinical Trial To Study Atrial Fibrillation
St. jude medical, inc. (nyse:stj) today announced that it is the leading sponsor of the catheter ablation versus anti-arrhythmic drug therapy for atrial fibrillation (cabana) trial. the pivotal tr
View full resource at medicalnewstoday.com
Tags: Heart Disease, Arrhythmia, Atrial Fibrillation, Drug, Clinical Trial
Most Recently Shared on June 15, 2009 at 12:14 pm By:
MedicalNewsToday: St. Jude Medical Announces Leading Sponsorship Of Landmark: http://tinyurl.com/lzkkyz Full http://tinyurl.com/kkqcs8
Advertisement
